Mitch Medical Healthcare

Summary and conclusion

PN is an effective and potentially lifesaving method of administering nutrition support therapy in patients who cannot receive adequate oral or enteral nutrition, but may be associated with several complications. Enteral nutrition is the preferred route of providing nutrition support therapy. Administration of PN is associated with significant adverse effects, and patients must be monitored closely. Patients receiving PN therapy are at risk for metabolic, infectious, and mechanical complications. Optimal design of a PN regimen is essential to minimize the risk of adverse effects and complications, and patients must be monitored closely while receiving PN in order to optimize outcomes.

Abbreviations Introduced in This Chapter

A. S. P. E. N, American Society ipf Pa rent era 1 a lid Enter a 1 Nutrition

AST Aspartate aminotransferase

ATP Adenosine triphosphate

BEE Basa 1 e ncrgy expenditure

BMI Bod y mas s index

HUD Beyond-use date

CIS: 2n-6 Llnoleic acid

CIS: 3n-3 a-Linolenic acid

C20; 4n-6 Aiachidonic acid

CA PD C ont i mi o u s a mbu latory per ito ne a Id i a lysis

CK RT C ont inuous rena 1 replacemen 11 he ra py

CSP	Compounded sterile preparations
HIT	H eparin-induçed thrombocytopenia
IRW	Ideal body weight
IHD	Intermit tenthemodia lysis
LDH	Lactate dehydrogenase
NG	Nasogastric
PICC	Peripherally inserted central venous catheter
PL	Phospholipid (s)
PN	Parenteral nutrition
PPN	Peripheral parenteral nutrition
/
REE	Resting energy expenditure
RMR	Resting metabolic rate
RQ	Respiratory quotient
SGA	Subjective global assessment
TEE	Total energy expenditure
TG	Triglyceride(s)
TNA	Total nutrient admixture
TPN	Total parenteral nutrition
USP 797	United States Pharmacopeia Chapter 797
vo3	Volume of oxygen consumption
vco2	Volume of carbon dioxide production

wwvit

^ Self-assessment questions and answers are available at ht-tp://www. mhpharmacotherapy. com/pp.html.

Was this article helpful?

0 0